Effects of gonadotropin-releasing hormone agonists on infertility

Phase 2

• Conditions: Diseases of the genitourinary system.; Non inflammatory disorders of female genital tract; N00-N99

• Registration Number: IRCT2015011920408N4
• Lead Sponsor: Vice chancellor for research, Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 110

Inclusion Criteria

Infertile women at age of =35 years; normal early follicular FSH; no medication in previous cycle; both tubes patency; presence of ovaries; no endometriosis; mild male subferiltiy. Exclusion criteria: Medical diseases; severe male infertility; poor response ovaries; peri-tubal adhesion.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pregnancy rate. Timepoint: Two weeks after intrauterine insemination. Method of measurement: Laboratory kits.

Secondary Outcome Measures

Name	Time	Method
Ovarian hyper stimulation syndrome rate. Timepoint: Human chorionic gonadotropin injection until two weeks. Method of measurement: Ultrasonography.;Ovarian hyper stimulation syndrome rate. Timepoint: From gonadotropin realesing hormone agonist injection day until two weeks. Method of measurement: Ultrasonography.;Estradiol levels. Timepoint: 12 and 36 hours post ovulation. Method of measurement: Laboratory kits.;Fullicular stimulating Hormone levels. Timepoint: 12 and 36 hours post ovulation. Method of measurement: Laboratory kits.